ImmuCell Corporation Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
ImmuCell Corporation (ICCC) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of $28.21 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2026-03-30
- ImmuCell Corporation effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2025 was $28.21K, a 42.46% decline from fiscal 2024.
- ImmuCell Corporation effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2024 was $49.03K, a 12.78% decline from fiscal 2023.
- ImmuCell Corporation effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2023 was $56.21K, a 53.37% increase from fiscal 2022.
- ImmuCell Corporation effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2022 was $36.65K, a 167.22% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-31 | $28.21K 10-K · filed 2026-03-30 |
| 2024-12-31 | $49.03K 10-K · filed 2026-03-30 |
| 2023-12-31 | $56.21K 10-K · filed 2025-03-28 |
| 2022-12-31 | $36.65K 10-K · filed 2024-04-01 |
| 2021-12-31 | $13.72K 10-K · filed 2023-03-29 |
| 2020-12-31 | $30.12K 10-K · filed 2022-03-30 |
| 2019-12-31 | $37.81K 10-K · filed 2020-03-27 |
| 2018-12-31 | $67.18K 10-K · filed 2020-03-27 |
| 2017-12-31 | $55.95K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |